Solid as a Rock: Creating a Strong Foundation for Developing First-in-Class Treatments to Fight Aggressive Cancers – A Chat with Elaine Sullivan, Co-Founder & CEO, Carrick Therapeutics

By Rich Soll, Senior Vice President, Research Service Division, WuXi AppTec (@richsollwx) In the life sciences, disruptive innovation is no longer the exception... Continue Reading


Brave Science: Putting the ‘Hutzpah’ in Early-Stage Drug Discovery – A Chat with Ehud Gazit, Academic Director, Blavatnik Center for Drug Development, Israel

By Rich Soll, SVP of Research Service Division at WuXi AppTec (@richsollwx) From developing new paradigms for early-stage drug discovery for rare and common dis... Continue Reading

wuxi_Charles Mowbray

Harnessing Science for the Most Neglected Diseases – A Chat with Charles Mowbray, Ph.D., Head of Drug Discovery, DNDi

By Rich Soll, VP of Research Service Division at WuXi AppTec (@richsollwx)  “Some of these diseases are rapidly fatal, cause huge loss of life, and have a huge ... Continue Reading